Research programme: HIV vaccines - The Scripps Research Institute

Drug Profile

Research programme: HIV vaccines - The Scripps Research Institute

Alternative Names: AIDS Vaccine - The Scripps Research Institute

Latest Information Update: 23 Nov 2016

Price : $50

At a glance

  • Originator The Scripps Research Institute
  • Class AIDS vaccines; Protein-vaccines
  • Mechanism of Action Immunogenetic stimulants; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical HIV infections

Most Recent Events

  • 07 Nov 2016 Preclinical trials in HIV infections in USA (Parenteral)
  • 07 Nov 2016 The Scripps Research Institute entered into a collaboration agreement to test PIKA adjuvant technology developed by Yisheng Biopharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top